A new genome analysis of parrots by a collaborative team led by Claudio Mello, M.D., Ph.D., published in the journal Current Biology, reveals genes that appear to be correlated to unexpectedly long...
Hold the date for the annual OHSU Commercialization Conference, hosted by Technology Transfer and Business Development. This year's theme of Fueling Health Care Innovation offers a platform for...
Blood clots contribute to dangerous, potentially deadly conditions, including venous thromboembolism and stroke. They are also a leading cause of death and long-term disability in the U.S. and...
The 2018 MedTech Alliance Showcase, hosted by Technology Transfer and Business Development, highlights the most promising early-stage breakthroughs at OHSU. This year, four inventors will have 10...
According to the National Institutes of Health, one in 10 Americans is impacted by one of more than 7,000 identified rare diseases. The majority of these diseases are genetic and do not have approved...
New research led by Rebecca Matro, M.D., assistant professor of gastroenterology in the OHSU School of Medicine, has confirmed that biologic therapies pose no health risks to infants of nursing...
New research for the first time reveals the three-dimensional structure of a membrane channel that is connected to many diseases and is critical in controlling blood pressure. The epithelial...
Xiangshu Xiao, Ph.D., and his team were recently awarded $120,000 to develop a new therapy for drug-resistant ovarian cancer. Ovarian cancer is the deadliest gynecological cancer in the U.S., and...
Physician-scientist Donald R. Sullivan, M.D. F ’13, M.A., M.C.R., is a core investigator of health services research and development in the Center to Improve Veteran Involvement in Care, V.A....
A multidisciplinary team of veterinarians and scientists at the Oregon National Primate Research Center has identified the first non-human primate model of neuronal ceroid lipofuscinosis, a broad...